Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Asset Utilization Ratio (2022 - 2025)

Historic Asset Utilization Ratio for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to 0.83.

  • bioAffinity Technologies' Asset Utilization Ratio fell 4137.04% to 0.83 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.83, marking a year-over-year decrease of 4137.04%. This contributed to the annual value of 1.27 for FY2024, which is 41188.48% up from last year.
  • Per bioAffinity Technologies' latest filing, its Asset Utilization Ratio stood at 0.83 for Q3 2025, which was down 4137.04% from 1.49 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Asset Utilization Ratio ranged from a high of 1.49 in Q2 2025 and a low of 0.0 during Q4 2022
  • Its 4-year average for Asset Utilization Ratio is 0.71, with a median of 0.72 in 2024.
  • As far as peak fluctuations go, bioAffinity Technologies' Asset Utilization Ratio skyrocketed by 11999364.82% in 2024, and later plummeted by 4137.04% in 2025.
  • Over the past 4 years, bioAffinity Technologies' Asset Utilization Ratio (Quarter) stood at 0.0 in 2022, then skyrocketed by 75078.36% to 0.28 in 2023, then skyrocketed by 420.91% to 1.43 in 2024, then tumbled by 41.97% to 0.83 in 2025.
  • Its last three reported values are 0.83 in Q3 2025, 1.49 for Q2 2025, and 1.46 during Q1 2025.